CATALOGO DEI PRODOTTI DELLA RICERCA

Granata, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.727
NA - Nord America 2.216
AS - Asia 1.569
SA - Sud America 243
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 6.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.177
RU - Federazione Russa 1.070
SG - Singapore 596
GB - Regno Unito 557
CN - Cina 546
IT - Italia 262
SE - Svezia 210
BR - Brasile 193
FR - Francia 167
VN - Vietnam 146
IE - Irlanda 137
HK - Hong Kong 125
DE - Germania 123
FI - Finlandia 87
ID - Indonesia 31
UA - Ucraina 26
AR - Argentina 25
KR - Corea 25
BE - Belgio 18
TR - Turchia 18
AT - Austria 17
IN - India 16
CA - Canada 15
JP - Giappone 13
MX - Messico 13
EC - Ecuador 10
PL - Polonia 10
ZA - Sudafrica 10
ES - Italia 7
NL - Olanda 7
IQ - Iraq 6
RO - Romania 6
BD - Bangladesh 4
IL - Israele 4
MA - Marocco 4
MY - Malesia 4
PK - Pakistan 4
UZ - Uzbekistan 4
VE - Venezuela 4
AU - Australia 3
CH - Svizzera 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
KE - Kenya 3
KG - Kirghizistan 3
PY - Paraguay 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BH - Bahrain 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.790
Salva come PNG Salva come JPEG
Città #
Southend 487
Moscow 369
Chandler 359
Singapore 297
Ashburn 196
Dallas 162
Jacksonville 155
Dublin 133
Hong Kong 124
Ann Arbor 108
Beijing 105
Woodbridge 96
New York 58
Wilmington 55
Lawrence 50
Princeton 50
Houston 45
Dong Ket 40
Verona 38
Jinan 36
Redmond 36
Columbus 31
The Dalles 31
Los Angeles 28
Nanjing 28
Redondo Beach 28
Shenyang 27
Ho Chi Minh City 24
Seattle 23
São Paulo 22
Helsinki 21
Council Bluffs 20
Hebei 20
Hanoi 19
Jakarta 19
Tianjin 18
Brussels 17
Kent 17
Munich 17
Santa Clara 17
Sindelfingen 17
Boardman 15
Ningbo 15
Lancaster 14
Rome 14
Buffalo 13
Taizhou 13
Tokyo 13
Vienna 13
Changsha 12
Atlanta 11
Padova 11
Zhengzhou 11
Brooklyn 10
Denver 10
Jiaxing 10
Seoul 10
Guangzhou 9
Nanchang 9
San Jose 9
Ankara 8
Auburn Hills 8
Bologna 8
Haikou 8
Hangzhou 8
Milan 8
Nuremberg 8
Porto Alegre 8
Redwood City 8
Rio de Janeiro 8
San Francisco 8
Chicago 7
London 7
Orem 7
Quito 7
Taiyuan 7
Turku 7
Boston 6
Phoenix 6
Venice 6
Warsaw 6
Washington 6
Biên Hòa 5
Fuzhou 5
Johannesburg 5
Lanzhou 5
Manchester 5
Montreal 5
Norwalk 5
Querétaro 5
Stockholm 5
Turin 5
Cambridge 4
Chennai 4
Esslingen am Neckar 4
Foggia 4
Frankfurt am Main 4
Genova 4
Kochi 4
Mexico City 4
Totale 3.907
Salva come PNG Salva come JPEG
Nome #
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 233
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 223
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 177
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 175
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 167
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 165
mTOR inhibitors and renal allograft: Yin and Yang. 164
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 164
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 161
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 159
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 159
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 158
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 158
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 155
Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. 154
DISTURBI PSICOLOGICI, QUALITÀ DI VITA E PRODUZIONE DI CITOCHINE NEI PAZIENTI IN EMODIALISI 153
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 153
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 152
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 149
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 147
Dialysis-related systemic microinflammation is associated with specific genomic patterns 145
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 143
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 141
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 140
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 138
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 138
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 136
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 133
Mitochondria: a new therapeutic target in chronic kidney disease. 131
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 131
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 131
mTOR Inhibition Role in Cellular Mechanisms 130
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 129
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 129
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 128
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 127
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 126
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 126
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 125
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 124
Analysis of urinary exosomes applications for rare kidney disorders. 120
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 116
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 105
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 104
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings 97
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease 95
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. 91
Kidney Allograft Fibrosis: What We Learned From Latest Translational Research Studies 87
Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury 72
Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis 62
Totale 6.926
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.330
article - articoli 21.323
book - libri 0
conference - conferenze 2.007
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.660
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 34 16 19 4 6 40 88
2021/2022399 25 76 11 67 8 17 28 31 12 9 25 90
2022/20231.002 62 140 83 172 85 228 8 51 119 6 32 16
2023/2024450 23 39 49 40 57 81 9 40 3 10 82 17
2024/20251.054 52 67 47 202 49 37 68 52 152 50 98 180
2025/20262.165 225 136 173 561 861 209 0 0 0 0 0 0
Totale 6.926